ALPHAHELIX MOL.DIAGN. SK1 Cash Flow-to-Debt Ratio
ALPHAHELIX MOL.DIAGN. SK1 cash flow-to-debt ratio. ALPHAHELIX MOL.DIAGN. SK1 (4MB) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2026, meaning its operating cash flow of €202.00K could theoretically repay 0% of its total liabilities (€12.31 Million) in one year. Check earnings quality score of ALPHAHELIX MOL.DIAGN. SK1 to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ALPHAHELIX MOL.DIAGN. SK1 (2022–2025)
Cash flow-to-debt ratio of ALPHAHELIX MOL.DIAGN. SK1 from 2022 to 2025. Historical debt coverage capacity for ALPHAHELIX MOL.DIAGN. SK1 across 4 annual periods. Check ALPHAHELIX MOL.DIAGN. SK1 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
ALPHAHELIX MOL.DIAGN. SK1 Cash Flow-to-Debt Ratio by Year (2022–2025)
ALPHAHELIX MOL.DIAGN. SK1 cash flow-to-debt ratio by year from 2022 to 2025. Year-by-year debt coverage analysis for ALPHAHELIX MOL.DIAGN. SK1. For the full cash flow conversion analysis, see ALPHAHELIX MOL.DIAGN. SK1 cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | €820.45K | €13.41 Million | ▲ +115.3% |
| 2024 | -0.40x | €-4.46 Million | €11.20 Million | ▲ +36.5% |
| 2023 | -0.63x | €-5.45 Million | €8.68 Million | ▼ -295.1% |
| 2022 | 0.32x | €2.87 Million | €8.91 Million | — |